Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system

Journal of Molecular Medicine

Volumn 92, Issue 2, 2014, Pages 185-196

  Guske, Katrin ^a   Schmitz, Boris ^a   Schelleckes, Michael ^a   Duning, Kerstin ^a   Kremerskothen, Joachim ^a   Pavenstädt, Hermann J ^a   Brand, Stefan Martin ^a   Brand, Eva ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Alternative promoter system; Cancer; Gene expression regulation; Hippo pathway; TCF7L2

Indexed keywords

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; CELL LINE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; EPITHELIAL CELLS; EXONS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRONS; KIDNEY; MUSCLE PROTEINS; NEUROBLASTOMA; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 84894045417     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1089-y     Document Type: Article

References (62)

1. Kremerskothen J, Plaas C, Büther K, Finger I, Veltel S, Matanis T, Liedtke T, Barnekow A (2003) Characterization of KIBRA, a novel WW domain-containing protein. Biochem Biophys Res Commun 300:862-867
2. Almeida OP, Schwab SG, Lautenschlager NT, Morar B, Greenop KR, Flicker L, Wildenauer D (2008) KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. J Cell Mol Med 12:1672-1676
3. Bates TC, Price JF, Harris SE, Marioni RE, Fowkes FG, Stewart MC, Murray GD, Whalley LJ, Starr JM, Deary IJ (2009) Association of KIBRA and memory. Neurosci Lett 458:140-143
4. Nacmias B, Bessi V, Bagnoli S, Tedde A, Cellini E, Piccini C, Sorbi S, Bracco L (2008) KIBRA gene variants are associated with episodic memory performance in subjective memory complaints. Neurosci Lett 436:145-147
5. Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ, Craig DW, Pearson JV, Huynh KD, Brunner F, Corneveaux J, Osborne D et al (2006) Common Kibra alleles are associated with human memory performance. Science 314:475-478
6. Schaper K, Kolsch H, Popp J, Wagner M, Jessen F (2008) KIBRA gene variants are associated with episodic memory in healthy elderly. Neurobiol Aging 29:1123-1125
7. Schneider A, Huentelman MJ, Kremerskothen J, Duning K, Spoelgen R, Nikolich K (2010) KIBRA: a new gateway to learning and memory? Front Aging Neurosci 2:4
8. Wersching H, Guske K, Hasenkamp S, Hagedorn C, Schiwek S, Jansen S, Witte V, Wellmann J, Lohmann H, Duning K et al (2011) Impact of common KIBRA allele on human cognitive functions. Neuropsychopharmacology 36:1296-1304
9. Burgess JD, Pedraza O, Graff-Radford NR, Hirpa M, Zou F, Miles R, Nguyen T, Li M, Lucas JA, Ivnik RJ et al (2011) Association of common KIBRA variants with episodic memory and AD risk. Neurobiol Aging 32:557.e1-557.e9
10. Corneveaux JJ, Liang WS, Reiman EM, Webster JA, Myers AJ, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Craig DW et al (2010) Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging 31:901-909
11. Rodríguez-Rodríguez E, Infante J, Llorca J, Mateo I, Sánchez-Quintana C, García-Gorostiaga I, Sánchez-Juan P, Berciano J, Combarros O (2009) Age-dependent association of KIBRA genetic variation and Alzheimer's disease risk. Neurobiol Aging 30:322-324
12. Büther K, Plaas C, Barnekow A, Kremerskothen J (2004) KIBRA is a novel substrate for protein kinase Czeta. Biochem Biophys Res Commun 317:703-707
13. Duning K, Schurek EM, Schlüter M, Bayer M, Reinhardt HC, Schwab A, Schaefer L, Benzing T, Schermer B, Saleem MA et al (2008) KIBRA modulates directional migration of podocytes. J Am Soc Nephrol 19:1891-1903
14. Kremerskothen J, Kindler S, Finger I, Veltel S, Barnekow A (2006) Postsynaptic recruitment of Dendrin depends on both dendritic mRNA transport and synaptic anchoring. J Neurochem 96:1659-1666
15. Mundel P, Heid HW, Mundel TM, Krüger M, Reiser J, Kriz W (1997) Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139:193-204
16. Rosse C, Formstecher E, Boeckeler K, Zhao Y, Kremerskothen J, White MD, Camonis JH, Parker PJ (2009) An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol 7:e1000235
17. Yoshihama Y, Sasaki K, Horikoshi Y, Suzuki A, Ohtsuka T, Hakuno F, Takahashi S, Ohno S, Chida K (2011) KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells. Curr Biol 21:705-711
18. Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H (2010) The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 18:309-316
19. Genevet A, Tapon N (2011) The Hippo pathway and apico-basal cell polarity. Biochem J 436:213-224
20. Xiao L, Chen Y, Ji M, Dong J (2011) KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. J Biol Chem 286:7788-7796
21. Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D (2010) Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 18:288-299
22. Boggiano JC, Fehon RG (2012) Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell 22:695-702
23. Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G, Pandolfi PP, Givol D, Strano S, Lu X et al (2008) PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell 32:803-814
24. Liu H, Jiang D, Chi F, Zhao B (2012) The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation. Protein Cell 3:291-304
25. Moleirinho S, Chang N, Sims AH, Tilston-Lünel AM, Angus L, Steele A, Boswell V, Barnett SC, Ormandy C, Faratian D et al (2012) KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals. Oncogene. http://www.nature.com/onc/journal/vaop/ncurrent/full/onc2012196a.html
26. Happé H, de Heer H, Peters DJ (2011) Polycystic kidney disease: the complexity of planar cell polarity and signaling during tissue regeneration and cyst formation. Biochim Biophys Acta 1812:1249-1255
27. Hohage H, Stachon A, Feidt C, Hirsch JR, Schlatter E (1998) Regulation of organic cation transport in IHKE-1 and LLC-PK1 cells. Fluorometric studies with 4-(4-dimethylaminostyryl)-N-methylpyridinium. J Pharmacol Exp Ther 286:305-310
28. Jessen H, Røigaard H, Riahi-Esfahani S, Jacobsen C (1994) A comparative study on the uptake of alpha-aminoisobutyric acid by normal and immortalized human embryonic kidney cells from proximal tubule. Biochim Biophys Acta 1190:279-288
29. Tveito G, Hansteen IL, Dalen H, Haugen A (1989) Immortalization of normal human kidney epithelial cells by nickel (II). Cancer Res 49:1829-1835
30. Orosz DE, Woost PG, Kolb RJ, Finesilver MB, Jin W, Frisa PS, Choo CK, Yau CF, Chan KW, Resnick MI et al (2004) Growth, immortalization, and differentiation potential of normal adult human proximal tubule cells. In Vitro Cell Dev Biol Anim 40:22-34
31. Liao Y, Lönnerdal B (2010) beta-Catenin/TCF4 transactivates miR-30e during intestinal cell differentiation. Cell Mol Life Sci 67:2969-2978
32. Schaefer BC (1995) Revolutions in rapid amplification of cDNA ends: new strategies for polymerase chain reaction cloning of full-length cDNA ends. Anal Biochem 227:255-273
33. Dördelmann C, Telgmann R, Brand E, Hagedorn C, Schröer B, Hasenkamp S, Baumgart P, Kleine-Katthöfer P, Paul M, Brand-Herrmann SM (2008) Functional and structural profiling of the human thrombopoietin gene promoter. J Biol Chem 283:24382-24391
34. Grabe N (2002) AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2:S1-S15
35. Messeguer X, Escudero R, Farré D, Núñez O, Martínez J, Albà MM (2002) PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18:333-334
36. Schmitz B, Salomon A, Rötrige A, Ritter M, Ringelstein EB, Fischer JW, Paul M, Brand E, Brand SM (2013) Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypes. Arterioscler Thromb Vasc Biol 33:871-880
37. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engström PG, Frith MC et al (2006) Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 38:626-635
38. Hochheimer A, Tjian R (2003) Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. Genes Dev 17:1309-1320
39. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y, Green RD, Ren B (2005) A high-resolution map of active promoters in the human genome. Nature 436:876-880
40. Lee MP, Howcroft K, Kotekar A, Yang HH, Buetow KH, Singer DS (2005) ATG deserts define a novel core promoter subclass. Genome Res 15:1189-1197
41. Tsuchihara K, Suzuki Y, Wakaguri H, Irie T, Tanimoto K, Hahimoto S, Matsushima K, Mizushima-Sugano J, Yamashita R, Nakai K et al (2009) Massive transcriptional start site analysis of human genes in hypoxia cells. Nucleic Acids Res 37:2249-2263
42. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ et al (2003) The UCSC genome browser database. Nucleic Acids Res 31:51-54
43. Thomas DJ, Rosenbloom KR, Clawson H, Hinrichs AS, Trumbower H, Raney BJ, Karolchik D, Barber GP, Harte RA, Hillman-Jackson J et al (2007) The ENCODE Project at UC Santa Cruz. Nucleic Acids Res 35:D663-D667
44. Core LJ, Waterfall JJ, Lis JT (2008) Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322:1845-1848
45. Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J, Lagarde J, Alioto T, Manzano C, Chrast J et al (2007) Prominent use of distal 5′ transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res 17:746-759
46. Seila AC, Calabrese JM, Levine SS, Yeo GW, Rahl PB, Flynn RA, Young RA, Sharp PA (2008) Divergent transcription from active promoters. Science 322:1849-1851
47. Kruglyak L, Nickerson DA (2001) Variation is the spice of life. Nat Genet 27:234-236
48. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
49. Zhao J, Schug J, Li M, Kaestner KH, Grant SF (2010) Disease-associated loci are significantly over-represented among genes bound by transcription factor 7 like 2 (TCF7L2) in vivo. Diabetologia 53:2340-2346
50. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T (1999) beta-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155:1033-1038
51. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512
52. Tetsu O, McCormick F (1999) beta-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426
53. Smale ST, Kadonaga JT (2003) The RNA polymerase II core promoter. Annu Rev Biochem 72:449-479
54. Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292
55. Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G, Markman M, Lamers W, Destree O, Clevers H (1998) Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol 18:1248-1256
56. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H (1998) Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 19:379-383
57. Li J, Sutter C, Parker DS, Blauwkamp T, Fang M, Cadigan KM (2007) CBP/p300 are bimodal regulators of Wnt signaling. EMBO J 26:2284-2294
58. Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM, van Es JH, Clevers H et al (2009) HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12:829-838
59. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF (2011) Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332:458-461
60. Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N (2010) Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 18:300-308
61. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM et al (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22:1962-1971
62. Roose J, Clevers H (1999) TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta 1424:M23-M37